Intradigm Corporation

Description

Simon has significant experience in strategy development, deal making and financing. This experience covers both small molecules and proteins and in recent years he has built significant experience in the area of Biosimilars. Simon is routinely asked to speak at conferences including attendance at the World Economic Forum as an invited entrepreneur in 2005.

He has over 17 years of experience in financial services. He started his career as a Technology Analyst at Duncan Lawrie then Credit Lyonnais Securities. In 2001, he co-founded Evolution Securities and ran the principal trading and market making arm, leaving in 2008. He has extensive experience in small companies and has had significant stakes in UK listed technology/biotech ventures.

Stephen Parker has over thirty years of experience working with and within the biotechnology and pharmaceutical industries. He was a Partner in Celtic Pharma from 2005 until 2013 and served as Executive Chairman of Cantab Biopharmaceuticals Limited. He has experience within the biotechnology sector as Chief Financial Officer of Oxford GlycoSciences (“OGS”) (2000-2002) and through several interim CEO projects. At OGS he played a leading role in raising £170m in the largest UK follow-on equity fundraising for a biotechnology company.

He is co-founder of the UK Stem Cell Foundation. Prior to joining OGS, he was a healthcare sector investment banker with experience in both big pharma and biotechnology. He was a senior banker with Barings, Warburg and Apax Partners. Stephen also has experience as a strategic consultant with PA Consulting Group. Stephen holds a DPhil. in biochemistry from Oxford University and an MBA from City University, London. He served on the Finance Committee of the UK BioIndustry Association from 2001 to 2009.

Products & services

Similar companies nearby